Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
How much proteinuria would warrant consideration of native kidney nephrectomies at the time of a kidney transplant?
Related Questions
Should all kidney transplant patients be started on statin therapy post operatively given their increased risk of CVD?
What is your approach for patients with a history of nephrolithiasis who are being evaluated for living kidney donation?
Do you recommend plasmapheresis prior to kidney transplantation for patients with elevated panel-reactive antibody percentages?
Would you rely on virtual crossmatch alone to proceed with a kidney transplant?
Do you recommend a metabolic evaluation in a kidney transplant patient with no prior history of nephrolithiasis who is found to have donor derived kidney stones?
Is there a BMI cutoff for which you no longer recommend kidney transplantation in a patient with end stage kidney disease and obesity?
How do you approach the management of a kidney transplant recipient who develops de novo donor-specific antibodies but shows no clinical signs of rejection or graft dysfunction?
Should HCQ be continued in an asymptomatic SLE patient who has received renal transplant?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
How do you approach chronic T cell mediated rejection when patient is intolerant to steroids?
